Dr R.P. Vijayanarayanan BDS
The surgical and high-precision engineering company that provides full jaw dental implant solutions has received a £4m investment from Business Growth Fund.
London-headquartered Evo will use the funding to expand its clinics, which feature on-site dental laboratories with the latest hi-tech medical manufacturing technology across the UK and explore international growth.
Evo’s advanced, proprietary solution provides life changing treatment for patients suffering from severe dental problems caused by advanced gum disease, congenital bone loss or accidents, and who require a full jaw reconstruction.
Designed and developed in-house by founder and CEO Dr R.P. Vijayanarayanan BDS (‘Vijay’) and a team of highly skilled dental surgeons, dental technicians and clinical CAD designers, Evo creates a bespoke new smile for every patient.
The process features digital scanning, prosthesis manufacturing, 3D printing, and high-precision milling machines with an accuracy of below ten microns, which is on par with aerospace engineering.
Dr Vijay said: “Evo is taking what’s possible in dentistry today far beyond the limits of what has previously been available.
“We’ve combined state-of-the-art engineering, innovation and first-class patient care to deliver a solution for the chronic types of tooth problems that inflict millions of people across the UK.
“We chose to partner with BGF because of their culture and approach. We have very ambitious expansion plans and wanted to work with someone who will support us longer-term, and also introduce us to people outside of our immediate space that can help us grow as a business.”
The business has centres in Heathrow and Liverpool and has completed more than 3,000 full-arch reconstructions for patients who have been referred by Evo’s growing network of dental practitioners or approached the company directly.
The team has the ability to treat 99% of people who receive a full clinical assessment, even if they have previously been told that their only option is dentures as they don’t have enough bone to anchor conventional dental implants.
Alistair Brew, BGF said: “Evo is an example of the best of British craftmanship, engineering and technology.
“The company has built a reputation for clinical excellence and is at the forefront of a nascent, but potentially very large market.
“Led by Dr Vijay, the team has huge ambitions to take this treatment across the UK and internationally, and we’re delighted to be backing them.”
The Adult Dental Health survey and ONS data suggest that more than five million people in UK could benefit clinically from this treatment.
Evo has seen increased demand from patients who want a permanent, comfortable and aesthetically appealing alternative.
BGF’s funding will be used to expand capacity at Evo’s current facilities, rollout new clinics in the UK and explore franchise opportunities internationally.
BGF has invested close to £100m into healthcare and medical technology companies across the UK.
These include pioneering internet pharmacy Pharmacy2U, dialysis provider Renal Services, discharge services provider CHS Healthcare and care home operators Springfield Healthcare, Dolphin Homes and The Good Care Group.
BGF has also backed online platforms for sourcing healthcare professionals Latum and Caresourcer, and personal data analytics company MyLife Digital.
Our BQ Bulletin emails will land in your inbox at 7.30am, Monday to Friday, with a mix of the latest local business news, national news, and features to inspire you. Sign up here!
Click here to read our privacy statement